Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 8, 2022
Grant Date -
May 20, 2021
app pub date -
Nov 25, 2020
filing date -
Mar 21, 2018
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully